20 June 2013
Keywords: USA, Helath care reform, Biosimilars, PhRMA, Massachusetts election
Article | 18 January 2010
The debate on US health care reform, and in particular the exclusivity of patent protection for biosimilars, or follow-on biological ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 January 2010
19 June 2013
© 2013 thepharmaletter.com